Ionis Pharmaceuticals, Inc.
IONS
$40.93
-$1.35-3.19%
Headlines
5/7/2024
-
SeekingAlpha
5/7/2024
-
Seeking Alpha: Transcripts
5/7/2024
-
TipRanks Financial Blog
5/7/2024
-
Zacks Investment Research
5/7/2024
-
Zacks Investment Research
5/7/2024
-
The Fly
5/7/2024
-
PR Newswire
Lisanti Capital Growth LLC Takes $3.16 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
5/7/2024
-
Ticker Report
5/6/2024
-
Zacks Investment Research
5/6/2024
-
Zolmax
5/2/2024
-
Tickeron - Stocks
5/1/2024
-
Zacks Investment Research
4/30/2024
-
Zacks Investment Research
4/28/2024
-
Ticker Report
4/27/2024
-
Ticker Report
4/26/2024
-
TipRanks Financial Blog
4/25/2024
-
Tickeron - Technical Analysis
4/25/2024
-
PR Newswire
4/23/2024
-
PR Newswire
4/19/2024
-
Zolmax
4/19/2024
-
Zolmax
4/14/2024
-
Ticker Report
4/14/2024
-
Simply Wall St
4/13/2024
-
Ticker Report
Filings
Wednesday, February 21, 2024
Sunday, December 31, 2023
Beginning of May (est)
Price History
Corporate Info
760 931 9200
2855 Gazelle Court
Carlsbad, CA 92010
Carlsbad, CA 92010
Business Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients...
more